Skyepharma Plc (SKYPY/SKYPY.PK) Wrap Up:

SkyePharma PLC, a specialty pharmaceutical company, develops new formulations using its drug delivery technologies. It offers inhalation products, such as Flutiform HFA-MDI, a fixed-dose combination of formoterol and fluticasone in a metered dose inhaler for the treatment of asthma/chronic obstructive pulmonary disease; Pulmicort HFA-MDI, which contains inhaled corticosteroid budesonide for the treatment of asthma; and formoterol HFA for the treatment of asthma/chronic obstructive pulmonary disease. The company also provides oral products, such as Paxil CR, an extended release serotonin re-uptake inhibitor for depression; Xatral OD, a once-daily version of sanofi-aventis’ alfuzosin hydrochlo...